Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Translational Lung Cancer Research|March 21, 2025
Unravelling the complexity of <i>EGFR</i>-mutated lung adenocarcinoma: a unique case report with histological transformations and co-alteration acquisitionAnissa Boutahir, Véronique Dalstein, Jean Baptiste Oudart, et al.
BMC Pulmonary Medicine|July 29, 2025
Pulmonary glue embolism after radiological embolization of pelvic varices: a case reportElise Longueville, Sandra Dury, Julien Ancel, et al.
BMC Pulmonary Medicine|March 16, 2024
Patient education needs in severe asthma, a pilot studyRodolphe Laurence, Julien Ancel, Maëva A Devilliers, et al.
Frontiers in Immunology|June 7, 2023
Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitorsJulien Ancel, Valérian Dormoy, Béatrice Nawrocki Raby, et al.
Translational Lung Cancer Research|May 19, 2025
Comparing neutrophil-to-lymphocyte ratio (NLR), absolute neutrophil count (ANC) and derived NLR as predictive biomarkers in first-line immunotherapy for non-small cell lung cancer: a retrospective studyElise Longueville, Maxime Dewolf, Véronique Dalstein, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2025
AXL expression to predict resistance to immunotherapy in metastatic non-small cell lung cancerJulien Ancel, Maxime Dewolf, Béatrice Nawrocki-Raby, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 25, 2024
High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPDJeanne-Marie Perotin, Anaëlle Muggeo, Quentin Lecomte-Thenot, et al.
Medicine|January 6, 2023
Clinical relevance of low bone density in cystic fibrosis adult patients: A pilot studySandra Dury, Julien Ancel, Bruno Ravoninjatovo, et al.
Respiratory Research|January 13, 2021
The elastin peptide VGVAPG increases CD4<sup>+</sup> T-cell IL-4 production in patients with chronic obstructive pulmonary diseaseFlora Lemaire, Sandra Audonnet, Jeanne-Marie Perotin, et al.
Cancers|September 25, 2019
Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLCJulien Ancel, Philippe Birembaut, Maxime Dewolf, et al.
Pageof 5